0001490109-20-000001.txt : 20201001 0001490109-20-000001.hdr.sgml : 20201001 20200930174758 ACCESSION NUMBER: 0001490109-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201001 DATE AS OF CHANGE: 20200930 EFFECTIVENESS DATE: 20201001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmot Therapeutics Inc. CENTRAL INDEX KEY: 0001490109 IRS NUMBER: 261872684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-376820 FILM NUMBER: 201213558 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 510-828-0102 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001490109 Carmot Therapeutics Inc. 740 Heinz Avenue Berkeley CA CALIFORNIA 94710 510-828-0102 DELAWARE None None Corporation true Stig K. Hansen 740 Heinz Avenue Berkeley CA CALIFORNIA 94710 Executive Officer Director Tim Kutzky 740 Heinz Avenue Berkeley CA CALIFORNIA 94710 Director Peter Svennilson 740 Heinz Avenue Berkeley CA CALIFORNIA 94710 Director Aetna Wun Trombley 740 Heinz Avenue Berkeley CA CALIFORNIA 94710 Director Biotechnology Decline to Disclose 06b false 2020-09-17 false true false 0 46882157 26282207 20599950 false 6 0 0 0 false Carmot Therapeutics Inc. /s/ Stig K. Hansen Stig K. Hansen Chief Executive Officer 2020-09-30